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registration algorithm underlying the average patient model might 
further reduce these baseline shifts, and enhance performance within 
the mediastinum. 
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Purpose/Objective: To provide a framework for selecting CTV-PTV 
margins in SBRT for achieving institution-specific requirements on 
target coverage. 
Materials and Methods: The Van Herk et al. (VH) formalism, providing 
margin components for systematic and random errors, was extended 
to allow selection of margins for SBRT. VH accounts for systematic 
errors, requesting that 90% of treated patients should have 100% of 
the CTV covered by at least 95% of the prescribed dose, providing the 
well-known margin component 2.5 ∑. We generalized this model to 
allow selection of margins for nearly (95-100%) full CTV coverage for a 
high percentage (90-98%) of treated patients. For random errors, a 
model based on VH was fitted using clinical dose distributions to 
account for typical SBRT prescription levels (67% and 80%), and the 
variety in dose gradients resulting from multiple beams. As a result, 
we propose margins to be selected according to: 
 where ∑eff and σeff represent effective standard deviations of the 
systematic and total random errors (consisting of intra and inter-
fraction random errors), respectively. A look-up graph is provided for 
α, requiring the radius (Reff) of a sphere with a volume equal to the 
clinical CTV.  
Monte Carlo simulations were used to test the overall performance of 
the framework using 25 liver SBRT treatment plans at 67% and 80% 
prescription dose levels, simulating clinically representative target 
displacements. To this end, artificial PTVs (conforming to the 
prescription iso-dose) were generated to verify the performance of 
the framework for perfectly conformal plans. Clinical PTVs were used 
to test the framework for not perfectly conformal plans, having parts 
of the PTV under-dosed. 
Results: Values for α strongly depend on the requested population 
coverage and CTV volume coverage (Vpres), see figure. For an almost 
full CTV coverage (>99%) and high population coverage (98%) with 
clinically representative displacements (∑ = 2 mm) and tumor sizes 
(Reff = 2 cm) a values are close to the 2.5 of the VH-recipe. Typically, 
margins of 7 mm are found for clinically representative systematic and 
random errors.  
For 98% of the simulated treatments with perfectly conformal plans at 
both prescription levels, the CTV coverage was between 99 and 100%, 
satisfying the selected requirements. The CTV coverage dropped 
below 99% when PTV coverage was compromised more than 2% in non-
conformal plans. Treated volume outside the PTV could not 
compensate for under-dosing other parts of the PTV.  
 Conclusions: A framework was developed to select CTV-PTV margins 
that realize institution-specific requirements for a pre-defined (high) 
percentage of patients and a pre-defined (almost full) CTV coverage. 
Margins can be determined from a simple formula and a look up 
graph. The recipe was demonstrated to obtain the expected CTV 
coverage in simulations of 25 SBRT liver treatments. 
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Purpose/Objective: Adaptive radiotherapy (ART) of bladder cancer 
often involves daily selection from a library of treatment plans. The 
plans may be derived from Boolean operations on the geometrical 
configurations of the bladder as seen in CBCTs acquired during the 
first days of treatment. The resulting plans are highly dependent on 
the bladder shapes in this limited sample of bladder geometries. The 
aim of this study was to investigate whether use of deformation 
vector fields derived from registration of these initial CBCTs to the 
planning CT results in more conformal plan libraries, evaluated on the 
basis of the treated volume across the treatment course. 
Materials and Methods: A series of bladder cancer patients originally 
treated using non-adaptive RT (with anisotropic margins of up to 2cm) 
were re-planned with two alternative ART strategies. The first 
strategy considered has recently been introduced clinically in our 
institution, and is a contour-based adaptive scheme based on the 
union of the bladder volumes from CBCT-scans of first week of 
treatment (Clinical ART). The 2nd strategy was based on deformation 
vector fields (DVFs) from deformable image registrations between the 
planning CT and each of the CBCTs from the first week of treatment 
(DVF-based ART). In the DVF-based approach the library plans were 
created using combinations of the overall mean DVF (mDVF) and its 
standard deviation (sdDVF). In all plans for both strategies, a 5 mm 
isotropic margin for intra-fractional bladder motion was used. The 
treatment course averaged volume of the selected target volumes was 
calculated for each patient using each of the ART strategies. The 
volume ratios relative to the non-adaptive treatment for the two 
strategies were compared using a Wilcoxon signed rank test. 
Normality of the distribution of DVFs was validated on voxel level by 
using the Shapiro-Wilk test. The study was based on five patients with 
a total of 146 daily CBCT scans. 
Results: The median and range of the volume ratio, compared to non-
adaptive RT (PTVART/ PTVnon-ART) was 0.60 [0.48-0.65] for DVF-based 
ART, compared to 0.71 [0.63-0.79] for our current clinical ART 
strategy (p=0.04). The number of fractions where the bladder was not 
completely covered with the large size plan was 5% and 10% for the 
clinical ART and DVF-based strategy, respectively. The Shapiro-Wilk 
test showed normally distributed deformation vectors over on average 
76% of the entire DVFs. 
  
Figure 1: The volume ratio PTVART/ PTVnon-ART over the entire 
treatment course of each patient is shown for the clinical treatment 
strategy as well as the DVF-based strategy. 
 
Conclusions: The use of DVFs from deformable registrations for 
creation of ART plan libraries is feasible and leads to an additional, 
statistically significant improvement in normal tissue sparing 
compared to an already highly conformal, clinically applied ART 
strategy.  
   
 
